Indications

Prescribing Information

Next Page Icon

Medication Guide

Next Page Icon
Potential OPDIVO® (nivolumab) user with her husband, petting a dog.
Potential OPDIVO® (nivolumab) user with her husband, petting a dog.

Getting an infusion for
gastric (stomach),
gastroesophageal junction,
or esophageal cancers

See how you may get an OPDIVO or OPDIVO-based combination infusion

Actor portrayals.

Advanced gastroesophageal cancer

OPDIVO with chemotherapy

For certain adults with previously untreated advanced gastric cancer, gastroesophageal junction cancer, or esophageal adenocarcinoma

Advanced esophageal squamous cell cancer

OPDIVO with chemotherapy

For certain adults with previously untreated advanced or metastatic esophageal squamous cell cancer

Advanced esophageal squamous cell cancer

OPDIVO + YERVOY

For certain adults with previously untreated advanced or metastatic esophageal squamous cell cancer

Esophageal or gastroesophageal junction cancer after surgery

OPDIVO

For certain adults with esophageal or gastroesophageal junction (GEJ) cancer that has been treated with chemoradiation followed by surgery to help prevent it from coming back

Previously treated advanced esophageal squamous cell cancer

OPDIVO

For certain adults who have had prior chemotherapy for advanced esophageal squamous cell cancer

OPDIVO will not work for everyone. Individual results may vary.

Hands perusing OPDIVO® (nivolumab) patient resources.

Helpful patient resources

Explore resources to help you along your treatment journey

Clinical trial results for OPDIVO® (nivolumab) and OPDIVO-based combinations.

Clinical trial results

Explore findings from clinical trials with OPDIVO and OPDIVO-based combinations



466-US-2400098   06/24